Deafness Ear, Nose and Throat
Conditions
Interventions
From March 2023 to March 2025, the research team of the Affiliated Hospital of Qinghai University strictly abided by ethical norms. With the full informed consent of the participants, the team systema
Sponsors
Qinghai Provincial Department of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Obtained written informed consent from the children's parents
Exclusion criteria
Exclusion criteria: Among the 549 collected newborn heel blood dried blood spot specimens, some were unqualified and cannot be used for subsequent testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neonatal deafness susceptibility genes detected using high-throughput sequencing of neonatal heel blood samples collected at a single timepoint. The results are categorized as carrying deafness susceptibility genes (positive) or not carrying deafness susceptibility genes (negative). | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
China
Contacts
Public ContactYi Wang
Outcome results
None listed